Providing Evidence-Based Approaches for Caregiver Stress Study
Launched by JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH · Jun 5, 2024
Trial Information
Current as of October 26, 2025
Recruiting
Keywords
ClinConnect Summary
The "Providing Evidence-Based Approaches for Caregiver Stress Study" is a clinical trial looking at how using adult day services affects stress for Black caregivers who are taking care of family members with dementia. The study aims to understand both how caregivers feel about their stress and how it affects their bodies. This research will involve 50 Black informal caregivers, focusing on their experiences and health while caring for loved ones diagnosed with Alzheimer's disease or related forms of dementia.
To participate in the study, caregivers must be at least 18 years old, self-identify as Black or African American, and be the primary caregiver for a family member with a dementia diagnosis. They should also be using adult day services for their loved one at least twice a week. Participants will engage in activities to help researchers gather information about their stress levels. This study is important because it aims to provide insights specifically about the experiences of Black caregivers, which can lead to better support and resources for them in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 18 years or older (male or female)
- • Self-identify as Black and/or African American,
- • Lives with a family member with a physician diagnosis of Alzheimer's disease or related dementia
- • Primary responsibility for care of the family member who has been diagnosed with Alzheimer's disease or related dementia
- • Utilize Adult Day Services at least two times a week for family member with Alzheimer's disease or related dementia
- Exclusion Criteria:
- • Either caregiver of client is in active treatment for a terminal illness or are in hospice.
About Johns Hopkins Bloomberg School Of Public Health
The Johns Hopkins Bloomberg School of Public Health is a leading institution dedicated to advancing public health research and education. Renowned for its rigorous academic programs and commitment to improving global health outcomes, the School conducts innovative clinical trials that address pressing health challenges. With a focus on evidence-based practices, multidisciplinary collaboration, and community engagement, the Bloomberg School leverages its extensive resources and expertise to contribute to the development of effective public health interventions and policies. Through its research endeavors, the School aims to enhance population health and inform health policy both locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Baltimore, Maryland, United States
Patients applied
Trial Officials
Lauren Parker, PhD, MPH
Principal Investigator
Johns Hopkins Bloomberg School of Public Health
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported